Noel T Brewer1, Marissa G Hall2, Joseph G L Lee2, Kathryn Peebles2, Seth M Noar3, Kurt M Ribisl1. 1. Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA. 2. Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA. 3. Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA School of Journalism and Mass Communication, University of North Carolina, Chapel Hill, North Carolina, USA.
Abstract
PURPOSE: Lab experiments on cigarette warnings typically use a brief one-time exposure that is not paired with the cigarette packs smokers use every day, leaving open the question of how repeated warning exposure over several weeks may affect smokers. This proof of principle study sought to develop a new protocol for testing cigarette warnings that better reflects real-world exposure by presenting them on cigarette smokers' own packs. METHODS: We tested a cigarette pack labelling protocol with 76 US smokers ages 18 and older. We applied graphic warnings to the front and back of smokers' cigarette packs. RESULTS: Most smokers reported that at least 75% of the packs of cigarettes they smoked during the study had our warnings. Nearly all said they would participate in the study again. Using cigarette packs with the study warnings increased quit intentions (p<0.05). CONCLUSIONS: Our findings suggest a feasible pack labelling protocol with six steps: (1) schedule appointments at brief intervals; (2) determine typical cigarette consumption; (3) ask smokers to bring a supply of cigarette packs to study appointments; (4) apply labels to smokers' cigarette packs; (5) provide participation incentives at the end of appointments; and (6) refer smokers to cessation services at end of the study. When used in randomised controlled trials in settings with real-world message exposure over time, this protocol may help identify the true impact of warnings and thus better inform tobacco product labelling policy. CLINICAL TRIAL NUMBER: NCT02247908. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
PURPOSE: Lab experiments on cigarette warnings typically use a brief one-time exposure that is not paired with the cigarette packs smokers use every day, leaving open the question of how repeated warning exposure over several weeks may affect smokers. This proof of principle study sought to develop a new protocol for testing cigarette warnings that better reflects real-world exposure by presenting them on cigarette smokers' own packs. METHODS: We tested a cigarette pack labelling protocol with 76 US smokers ages 18 and older. We applied graphic warnings to the front and back of smokers' cigarette packs. RESULTS: Most smokers reported that at least 75% of the packs of cigarettes they smoked during the study had our warnings. Nearly all said they would participate in the study again. Using cigarette packs with the study warnings increased quit intentions (p<0.05). CONCLUSIONS: Our findings suggest a feasible pack labelling protocol with six steps: (1) schedule appointments at brief intervals; (2) determine typical cigarette consumption; (3) ask smokers to bring a supply of cigarette packs to study appointments; (4) apply labels to smokers' cigarette packs; (5) provide participation incentives at the end of appointments; and (6) refer smokers to cessation services at end of the study. When used in randomised controlled trials in settings with real-world message exposure over time, this protocol may help identify the true impact of warnings and thus better inform tobacco product labelling policy. CLINICAL TRIAL NUMBER: NCT02247908. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Authors: James F Thrasher; Matthew C Rousu; Rafael Anaya-Ocampo; Luz Myriam Reynales-Shigematsu; Edna Arillo-Santillán; Mauricio Hernández-Avila Journal: Addict Behav Date: 2007-06-12 Impact factor: 3.913
Authors: Jessica K Pepper; Paul L Reiter; Annie-Laurie McRee; Linda D Cameron; Melissa B Gilkey; Noel T Brewer Journal: J Adolesc Health Date: 2012-11-30 Impact factor: 5.012
Authors: Jennifer Cantrell; Donna M Vallone; James F Thrasher; Rebekah H Nagler; Shari P Feirman; Larry R Muenz; David Y He; Kasisomayajula Viswanath Journal: PLoS One Date: 2013-01-14 Impact factor: 3.240
Authors: Noel T Brewer; Marissa G Hall; Seth M Noar; Humberto Parada; Al Stein-Seroussi; Laura E Bach; Sean Hanley; Kurt M Ribisl Journal: JAMA Intern Med Date: 2016-07-01 Impact factor: 21.873
Authors: Kathryn Peebles; Marissa G Hall; Jessica K Pepper; M Justin Byron; Seth M Noar; Noel T Brewer Journal: J Adolesc Health Date: 2016-09-16 Impact factor: 5.012
Authors: James F Thrasher; Noel T Brewer; Jeff Niederdeppe; Ellen Peters; Andrew A Strasser; Rachel Grana; Annette R Kaufman Journal: Nicotine Tob Res Date: 2019-06-21 Impact factor: 4.244
Authors: Seth M Noar; Dannielle E Kelley; Marcella H Boynton; Jennifer C Morgan; Marissa G Hall; Jennifer R Mendel; Kurt M Ribisl; Noel T Brewer Journal: Prev Med Date: 2017-09-08 Impact factor: 4.018
Authors: Jennifer C Morgan; Shelley D Golden; Seth M Noar; Kurt M Ribisl; Brian G Southwell; Michelle Jeong; Marissa G Hall; Noel T Brewer Journal: Soc Sci Med Date: 2018-10-03 Impact factor: 4.634
Authors: Marissa G Hall; Paschal Sheeran; Seth M Noar; Marcella H Boynton; Kurt M Ribisl; Humberto Parada; Trent O Johnson; Noel T Brewer Journal: Tob Control Date: 2017-12-16 Impact factor: 7.552